MYCN and neuroblastoma: Overall, these data are consistent with the ability of CYC065 to selectively deplete MYCN and thus preferentially downregulate these highly MYCN-occupied genes that crosscorrelate with the MYCN-associated adrenergic gene expression program that is essential for NB growth.